Welcome to our dedicated page for METTLER TOLEDO INTERNATIONAL INC/ SEC filings (Ticker: MTD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on METTLER TOLEDO INTERNATIONAL INC/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into METTLER TOLEDO INTERNATIONAL INC/'s regulatory disclosures and financial reporting.
Mettler-Toledo International (MTD) disclosed an insider equity award. On 11/11/2025, a company officer (Head of Asia & Pacific) acquired 67 shares of common stock at $0, bringing direct holdings to 542 shares after the transaction.
The insider was also granted stock options for 175 shares at an exercise price of $1,445.06, expiring on 11/11/2035. The options vest in five equal annual installments beginning on 11/11/2026.
Mettler-Toledo International (MTD) reported an insider transaction by its Chief Human Resources Officer. On 11/11/2025, the officer acquired 46 shares of common stock at $0, bringing direct beneficial ownership to 446 shares. The officer was also granted a stock option for 120 shares at an exercise price of $1,445.06 per share, expiring on 11/11/2035. The option vests annually in five equal installments beginning on 11/11/2026.
Mettler-Toledo International (MTD) reported an insider equity award for its Head of Process Analytics on 11/11/2025. The officer acquired 65 shares of common stock at a stated price of $0, bringing beneficial ownership to 159 shares, held directly.
The officer also received 170 stock options with an exercise price of $1,445.06, expiring on 11/11/2035. Per the filing, these options vest in five equal annual installments beginning on 11/11/2026.
Mettler-Toledo International (MTD) reported insider activity by its Chief Financial Officer. On 11/11/2025, the CFO acquired 192 common shares at $0, exercised stock options for 1,145 shares at $397.95 and 750 shares at $671.60, and sold 1,855 shares at an average $1,455.47 and 40 shares at an average $1,457.89. Following these transactions, direct ownership was 5,288 shares.
Separately, the CFO received a new stock option grant for 500 shares at an exercise price of $1,445.06, vesting in five equal annual installments beginning 11/11/2026 and expiring 11/11/2035.
Mettler-Toledo International (MTD) officer (Head of Eur & NA Market Orgs) reported insider transactions dated 11/11/2025. The filing shows two option exercises and a subsequent open-market sale. The officer exercised 3,295 options at $671.6 per share and 3,585 options at $595.31 per share. The officer then sold 6,880 shares at $1,450 per share. Following these transactions, the officer directly owned 187 shares.
The officer also received a new grant of 370 stock options with a $1,445.06 exercise price, first exercisable on 11/11/2026 and expiring on 11/11/2035. Per the footnotes, these options vest annually in five equal installments beginning on the first anniversary of the grant date. Previously granted options from 2018 and 2019 were fully exercised as reflected in the table.
Mettler-Toledo International Inc. (MTD) director reported equity awards on a Form 4. On 11/11/2025, the insider acquired 63 shares of common stock at $0, bringing directly held shares to 207. The insider also received a stock option for 162 shares at an exercise price of $1,445.06, first exercisable on 11/11/2026 and expiring on 11/11/2035. The options vest in two equal annual installments beginning on the first anniversary of the grant.
Mettler-Toledo International (MTD) reported an insider equity change by a director on 11/11/2025.
The director acquired 63 shares of common stock at a reported price of $0, bringing beneficial ownership to 183 shares held directly.
On the same date, the director was granted a stock option for 162 shares with an exercise price of $1,445.06, first exercisable on 11/11/2026 and expiring on 11/11/2035. The option vests in two equal annual installments beginning on the first anniversary of the grant.
Mettler Toledo International (MTD) reported an insider equity award. A director acquired 63 shares of common stock on 11/11/2025 at a stated price of $0, bringing directly owned common shares to 146 after the transaction.
The director was also granted 162 stock options with an exercise price of $1,445.06, expiring on 11/11/2035. These options vest in two equal annual installments beginning on the first anniversary of the grant, with initial exercisability on 11/11/2026.
Mettler-Toledo International (MTD) reported an insider transaction by a director on 11/11/2025. The filing shows an acquisition of 91 shares of common stock at $0, bringing the director’s direct beneficial ownership to 374 shares.
The director also received a stock option grant covering 162 shares at an exercise price of $1,445.06, vesting annually in two equal installments beginning 11/11/2026 and expiring on 11/11/2035. Indirect holdings are listed as 19,427 shares via SRB Investments LLC and 32,983 shares via Teaghlach LLC.
Mettler-Toledo International (MTD) director reported insider activity. On 11/11/2025, the director acquired 63 shares of common stock at $0 and was granted options to buy 162 shares at an exercise price of $1,445.06 per share. The options begin to vest in two equal annual installments starting on the first anniversary of the grant and expire on 11/11/2035. Following these transactions, the director beneficially owned 63 shares and 162 options, held directly.